معرفی
Harvey Koh serves as a Research Fellow at Monash University's Centre for Medicine Use and Safety within the Faculty of Medicine, Nursing and Health Sciences. His research integrates artificial intelligence with pharmaceutical and medical applications, focusing particularly on medication adherence patterns and cardiovascular disease management through analysis of large administrative healthcare datasets.
His research interests span Health Economics (including cost-effectiveness analysis and health technology assessment), Pharmacoepidemiology, and Artificial Intelligence applications in Digital Health. Dr. Koh specializes in applying machine learning techniques, statistical signal processing, and computational neuroscience methods to analyze medication usage patterns, particularly examining cardiovascular medications in patients with diabetes and lipid disorders.
His recent publications demonstrate a strong focus on medication adherence patterns, particularly examining cardiovascular medications in type 2 diabetes patients and lipid-modifying agents across cardiovascular risk groups. The research consistently employs advanced analytical methods including group-based trajectory analysis and large administrative data mining to identify patient patterns and improve risk stratification.
Dr. Koh actively collaborates with researchers including Talic, Zomer, Orman, and Gasevic, with recent work published in high-impact journals such as Diabetes Research and Clinical Practice, Journal of Clinical Lipidology, and PLoS ONE. His research output has shown consistent growth with multiple publications in 2024-2025, indicating an active research trajectory in medical data science and pharmaceutical outcomes research.
